Technical Specification Ultralieve® PRO

Technical Specification Ultralieve® PRO

• Power supply:
  Input: AC 100-240V, 50/60 Hz, 0.35A
  Output: DC 15V, 1.2A
• Frequency: 1MHz (±10%)
• Mode: 3 levels (“L” low, “M” medium, “H” high)
• Time: 5, 10 or 15 minutes with auto turn off
• Power output: (0.7W/cm2 (L), 1.0W/cm2 (M), 1.2W/cm2 (H)
• Duty factor: 30% (L), 40% (M), 50% (H)
• RBN: < 8.0
• Rated output power: 9.6W (±20%)
• Effective intensity: 2.4W/cm2 (±20%)
• AER: 4 cm2
• Beam type: Collimated
• Modulation wave shape: 100Hz (± 10%)
• Wave form: Pulsed

Contra-indications

Ultralieve® PRO should not be...

• Used for the treatment of malignancy (application over a tumour)
• Used on the skin over metal implants, including pacemakers or other electronic implants.
• Used on an Infected or bleeding area which is to be treated
• Used on the skin over vascular abnormalities (such as haemangioma, capillary, lymphatic, arterial or arterio-venous malformations)
• Used directly on the abdomen of pregnant women
• Applied directly over active epiphysis regions (growth plates), over the eyes, skull or testes
• Used over open wounds
• Used by individuals who do not comprehend the instructions for application

Precautions

• Clean the transducer head completely after use as this will prevent any possible cross-infection to other users.
• Keep out of the reach of children.
• People with local circulatory insufficiency should consult their health practitioner before use.
• Do not use on de-sensitised (numb, hypoaesthesia) areas of the skin (e.g. diabetic neuropathy).
• The socket outlet should be installed near the equipment and should be easily accessible.